Page last updated: 2024-10-23

bromhexine and Pneumothorax

bromhexine has been researched along with Pneumothorax in 1 studies

Bromhexine: A mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. (From Martindale, The Extra Pharmacopoeia, 30th ed, p744)
bromhexine : A substituted aniline that is 2,4-dibromoaniline which is substituted at position 6 by a [cyclohexyl(methyl)amino]methyl group. It is used (as the monohydrochloride salt) as a mucolytic for the treatment of respiratory disorders associated with productive cough (i.e. a cough characterised by the production of sputum).

Pneumothorax: An accumulation of air or gas in the PLEURAL CAVITY, which may occur spontaneously or as a result of trauma or a pathological process. The gas may also be introduced deliberately during PNEUMOTHORAX, ARTIFICIAL.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lachmann, B1
Tischer, AB1
Grossmann, G1
Robertson, B1

Other Studies

1 other study available for bromhexine and Pneumothorax

ArticleYear
Lung compliance and alveolar expansion in the artificially ventilated premature newborn rabbit after maternal treatment with ambroxol.
    Respiration; international review of thoracic diseases, 1981, Volume: 42, Issue:3

    Topics: Ambroxol; Animals; Animals, Newborn; Bromhexine; Female; Lung; Lung Compliance; Maternal-Fetal Excha

1981